Actively Recruiting
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
Led by Shanghai Zhongshan Hospital · Updated on 2025-06-10
30
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Androgenetic Alopecia (AGA) in female adults. The main question it aims to answer is: • Does DHA increase terminal hair follicles in the vertex area. Researchers will compare oral DHA plus topical minoxidil to topical minoxidil alone in female patients with AGA to see if DHA works to alleviate AGA. Participants will: * Receive oral DHA every day plus topical minoxidil or use topical minoxidil alone for 6 months. * Visit the clinic once every month for checkups and tests.
CONDITIONS
Official Title
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinically diagnosed with androgenetic alopecia (AGA)
- No pregnancy plans within the next 6 months
- Female aged 18 to 40 years
You will not qualify if you...
- Received systemic medications for hair loss within the past 2 months
- Used topical medication for hair loss within the past 2 weeks
- Pregnancy or lactation
- Known severe diseases of vital organs such as heart, liver, or kidney
- Presence of malignancies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
L
Lujuan GAO, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here